Evidence map›Paper›PMID 39311211›Full record

ArticleInfectious disease reports2024

HEV Infection in the Context of Prior HBV-Related Liver Injury: Case Series.

Mihaela-Cristina Olariu, Mihai-Cezar Filipescu, Andreea Marilena Pauna, Madalina Simoiu, Alina Maria Borcan

Abstract readCase Reports
In one paragraph

Article in Infectious disease reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mihaela-Cristina OlariuDepartment of Infectious Diseases, University of Medicine and Pharmacy "Carol Davila", 020021 Bucharest, Romania.ORCID 0000-0002-3442-2338
Mihai-Cezar FilipescuNational Institute for Infectious Diseases "Matei Balș", 021105 Bucharest, Romania.
Andreea Marilena PaunaDepartment of Epidemiology I, University of Medicine and Pharmacy "Carol Davila", 020021 Bucharest, Romania.
Madalina SimoiuNational Institute for Infectious Diseases "Matei Balș", 021105 Bucharest, Romania.
Alina Maria BorcanNational Institute for Infectious Diseases "Matei Balș", 021105 Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis E virus (HEV) is a common cause of acute hepatitis, with increasing incidence in Europe, including Romania. Concurrently, Romania has a high prevalence of chronic hepatitis B (CHB). There is limited research on the clinical presentation and outcomes of HEV infection in patients with pre-existing chronic hepatitis B (CHB), especially in resource-rich settings. Most literature data come from South, East, and Southeast Asia. A review of the literature on HEV and HBV co-infection indicates a severe prognosis, particularly in patients with underlying liver disease. However, the cases in this study, which did not display cirrhosis, showed varied outcomes. The role of anti-HBV treatment in improving prognosis remains uncertain and warrants further investigation. Acute HEV infection superimposed on chronic HBV infection poses significant clinical challenges, with outcomes ranging from full recovery to fatality. Preventive measures, including sanitation and vaccination against HBV, are crucial. More studies are needed to establish effective treatment protocols for this co-infection. In this study, we will analyze the clinical setting, diagnosis, particularities, and outcomes of five such cases of dual hepatotropic viral infection recorded over a period of 6 years (2018-2023) at a large Infectious Diseases clinic in Bucharest, Romania.

Indexed as

co-infectionHBVhepatitisHEVsuperinfection

Identifiers

PMID39311211
PMCPMC11417802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.